Versant Vantage I GP LP

-

Director Information, Funds, Firms

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Versant Vantage I GP LP
FirmVersant Venture Management LLC
AddressOne Sansome Street, Suite 3630
San Francisco, CA 94104
Source
Associated Funds Form D Role 2011 - 2026 Raised AUM
Versant Venture Management LLC
Versant Vantage I LP 021-334361 Director

of 150.0 M
69.9 M
Related People Network
Network #136 at Versant Venture Management LLC — files alongside 6 co-filers
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-29 Sell 52,305 $9.08 474,929
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-29 Sell 15,600 $9.41 146,796
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Sell 89,990 $9.66 869,303
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Other 17,595 $0.00
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Other 20,397 $0.00
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Other 20,397 $0.00
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Other 1,019,867 $0.00
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Other 366,590 $0.00
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Other 5,454 $0.00
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Other 5,454 $0.00
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Other 5,499 $0.00
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Other 5,499 $0.00
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-10-28 Other 17,595 $0.00
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-09-20 Sell 1,132,566 $6.53 7,395,656
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-09-13 Sell 9,269 $6.16 57,097
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-09-12 Sell 16,047 $6.00 96,282
Monte Rosa Therapeutics Inc GLUE
Common Stock
2024-09-11 Sell 541,897 $6.00 3,251,382
Contineum Therapeutics Inc CTNM
Series C Preferred Stock · derivative
2024-04-09 Conversion 275,769
Contineum Therapeutics Inc CTNM
Series C Preferred Stock · derivative
2024-04-09 Conversion 689
Contineum Therapeutics Inc CTNM
Series A-1 Preferred Stock · derivative
2024-04-09 Conversion 1,423,119
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com